AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter study.

Artificial Intelligence Body Composition Hepatocellular Carcinoma Transarterial Chemoembolization

Journal

JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 21 10 2023
revised: 17 05 2024
accepted: 23 05 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

Body composition assessment (BCA) parameters have recently been identified as relevant prognostic factors for patients with hepatocellular carcinoma (HCC). Herein, we aimed to investigate the role of BCA parameters for prognosis prediction in patients with HCC undergoing transarterial chemoembolization (TACE). This retrospective multicenter study included a total of 754 treatment-naïve patients with HCC who underwent TACE at six tertiary care centers between 2010-2020. Fully automated artificial intelligence-based quantitative 3D volumetry of abdominal cavity tissue composition was performed to assess skeletal muscle volume (SM), total adipose tissue (TAT), intra- and intermuscular adipose tissue, visceral adipose tissue, and subcutaneous adipose tissue (SAT) on pre-intervention computed tomography scans. BCA parameters were normalized to the slice number of the abdominal cavity. We assessed the influence of BCA parameters on median overall survival and performed multivariate analysis including established estimates of survival. Univariate survival analysis revealed that impaired median overall survival was predicted by low SM ( SM is an independent prognostic factor for survival prediction. Thus, the integration of SM into novel scoring systems could potentially improve survival prediction and clinical decision-making. Fully automated approaches are needed to foster the implementation of this imaging biomarker into daily routine. Body composition assessment parameters, especially skeletal muscle volume, have been identified as relevant prognostic factors for many diseases and treatments. In this study, skeletal muscle volume has been identified as an independent prognostic factor for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Therefore, skeletal muscle volume as a metaparameter could play a role as an opportunistic biomarker in holistic patient assessment and be integrated into decision support systems. Workflow integration with artificial intelligence is essential for automated, quantitative body composition assessment, enabling broad availability in multidisciplinary case discussions.

Sections du résumé

Background & Aims UNASSIGNED
Body composition assessment (BCA) parameters have recently been identified as relevant prognostic factors for patients with hepatocellular carcinoma (HCC). Herein, we aimed to investigate the role of BCA parameters for prognosis prediction in patients with HCC undergoing transarterial chemoembolization (TACE).
Methods UNASSIGNED
This retrospective multicenter study included a total of 754 treatment-naïve patients with HCC who underwent TACE at six tertiary care centers between 2010-2020. Fully automated artificial intelligence-based quantitative 3D volumetry of abdominal cavity tissue composition was performed to assess skeletal muscle volume (SM), total adipose tissue (TAT), intra- and intermuscular adipose tissue, visceral adipose tissue, and subcutaneous adipose tissue (SAT) on pre-intervention computed tomography scans. BCA parameters were normalized to the slice number of the abdominal cavity. We assessed the influence of BCA parameters on median overall survival and performed multivariate analysis including established estimates of survival.
Results UNASSIGNED
Univariate survival analysis revealed that impaired median overall survival was predicted by low SM (
Conclusions UNASSIGNED
SM is an independent prognostic factor for survival prediction. Thus, the integration of SM into novel scoring systems could potentially improve survival prediction and clinical decision-making. Fully automated approaches are needed to foster the implementation of this imaging biomarker into daily routine.
Impact and implications UNASSIGNED
Body composition assessment parameters, especially skeletal muscle volume, have been identified as relevant prognostic factors for many diseases and treatments. In this study, skeletal muscle volume has been identified as an independent prognostic factor for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Therefore, skeletal muscle volume as a metaparameter could play a role as an opportunistic biomarker in holistic patient assessment and be integrated into decision support systems. Workflow integration with artificial intelligence is essential for automated, quantitative body composition assessment, enabling broad availability in multidisciplinary case discussions.

Identifiants

pubmed: 39139458
doi: 10.1016/j.jhepr.2024.101125
pii: S2589-5559(24)00129-0
pmc: PMC11321290
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101125

Informations de copyright

© 2024 The Authors.

Auteurs

Lukas Müller (L)

Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Aline Mähringer-Kunz (A)

Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Timo Alexander Auer (TA)

Department of Radiology, Charité - University Medicine Berlin, Berlin, Germany.
Berlin Institute of Health at Charité - University Medicine Berlin, Berlin, Germany.

Uli Fehrenbach (U)

Department of Radiology, Charité - University Medicine Berlin, Berlin, Germany.

Bernhard Gebauer (B)

Department of Radiology, Charité - University Medicine Berlin, Berlin, Germany.

Johannes Haubold (J)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Institute for AI in Medicine (IKIM), University Hospital Essen, Essen, Germany.

Benedikt Michael Schaarschmidt (BM)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Moon-Sung Kim (MS)

Institute for AI in Medicine (IKIM), University Hospital Essen, Essen, Germany.

René Hosch (R)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Institute for AI in Medicine (IKIM), University Hospital Essen, Essen, Germany.

Felix Nensa (F)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Institute for AI in Medicine (IKIM), University Hospital Essen, Essen, Germany.

Jens Kleesiek (J)

Institute for AI in Medicine (IKIM), University Hospital Essen, Essen, Germany.

Thierno D Diallo (TD)

Department of Diagnostic and Interventional Radiology, Freiburg University Hospital, Freiburg, Germany.

Michel Eisenblätter (M)

Department of Diagnostic and Interventional Radiology, Freiburg University Hospital, Freiburg, Germany.
Department of Diagnostic and Interventional Radiology, Medical Faculty OWL, Bielefeld University, Bielefeld, Germany.

Hanna Kuzior (H)

Department of Diagnostic and Interventional Radiology, Freiburg University Hospital, Freiburg, Germany.

Natascha Roehlen (N)

Department of Medicine II, Freiburg University Hospital, Freiburg, Germany.

Dominik Bettinger (D)

Department of Medicine II, Freiburg University Hospital, Freiburg, Germany.

Verena Steinle (V)

Department of Diagnostic and Interventional Radiology, University Medical Center Heidelberg, Heidelberg, Germany.

Philipp Mayer (P)

Department of Diagnostic and Interventional Radiology, University Medical Center Heidelberg, Heidelberg, Germany.

David Zopfs (D)

Department of Radiology, University Hospital Cologne, Cologne, Germany.

Daniel Pinto Dos Santos (D)

Department of Radiology, University Hospital Cologne, Cologne, Germany.
Department of Radiology, University Hospital of Frankfurt, Frankfurt, Germany.

Roman Kloeckner (R)

Institute of Interventional Radiology, University Hospital of Schleswig-Holstein - Campus Lübeck, Lübeck, Germany.

Classifications MeSH